Steven Pascoe

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

Steven Pascoe, Nicholas Locantore, Mark T. Dransfield et al. · The Lancet Respiratory Medicine · 2015 · 733 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Helen Barnacle, Ruby Birk et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 330 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

Laurie A. Lee, Zelie Bailes, Neil Barnes et al. · The Lancet Respiratory Medicine · 2020 · 258 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +12

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Courtney Crim, Gerard J. Criner et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 251 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16